Summary
Updated Aug 31, 2026
Douglas K. Bratton files SEC Form 4 reports at Aquestive Therapeutics, Inc. (AQST). 1 SEC Form 4 filing on record, dated 4 December 2024.
Recent Transactions
1Every recent SEC Form 4 transaction Douglas K. Bratton has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Douglas K. Bratton files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Daniel Barber - $1.65M of AQST open-market activity in the last 12 months
- Cassie Jung - $976K of AQST open-market activity in the last 12 months
- Peter E. Boyd - $337K of AQST open-market activity in the last 12 months
- A. Ernest Toth Jr. - $243K of AQST open-market activity in the last 12 months
- Lori J. Braender - $167K of AQST open-market activity in the last 12 months
- Carl N. Kraus - $142K of AQST open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Douglas K. Bratton?
Douglas K. Bratton is a corporate insider of Aquestive Therapeutics, Inc. (AQST). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Douglas K. Bratton last file a Form 4?
The only primary Form 4 on record is dated 4 December 2024.
Where can I see all of Douglas K. Bratton's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Douglas K. Bratton and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
